Clinical Trial Update: Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase II trial evaluating an EBV-derived dendritic cell vaccine in autologous stem cell transplantation for Hodgkin lymphoma and non-Hodgkin lymphoma has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• EBV-derived dendritic cell vaccine

Snippet

Sponsor: David Rizzieri, MD | Conditions: Hodgkin Lymphoma, Non-Hodgkin Lymphoma | Phase 2 | Status: WITHDRAWN